Exact Sciences

EXACT Sciences Corporation develops deoxyribonucleic acid (DNA)-based technologies for use in the detection of cancer. The Company has selected colorectal cancer as the first application of its technologies. The Company has licensed certain of its technologies, on an exclusive basis through December 2010, to Laboratory Corporation of America Holdings (LabCorp). LabCorp developed and commercially offered PreGen-Plus, its first generation non-invasive stool-based DNA colorectal cancer screening service for the average-risk population. (Source: 10-K)

Scholarships

There are no scholarships at this time

 Events

There are no events at this time

Company Data on Exact Sciences
provided by Owler


 

Exact Sciences is hiring for these positions

Show me: All available jobs
loading